We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Minimally Invasive Alternatives to Surgery

By HospiMedica staff writers
Posted on 21 Mar 2001
Research on three minimally invasive procedures was presented at the annual meeting of the Society of Cardiovascular & Interventional Radiology (SCVIR) in San Antonio (TX, USA). More...
SCVIR is a professional association for doctors who specialize in minimally invasive procedures that are alternatives to surgery.

A new treatment uses lasers to eradicate varicose veins, according to preliminary research from Cornell University Medical Center (New York, NY, USA). The minimally invasive treatment is simpler and less costly than the surgical alternative. Most patients can return to normal activity immediately. The treatment is now being used at five centers in the United States.

Stent-graft repair of abdominal aortic aneurysms appears to be replacing conventional surgery as a first-line treatment. More than 30 research papers tracking more than 3,000 patients were presented at the meeting. Results show the minimally invasive treatment is successful and results in far fewer complications—including stroke—than traditional surgery.

A genetically engineering modification of tissue plasminogen activator (tPA) called Reteplase may be an effective stroke therapy, extending the treatment window from three to six hours, suggests preliminary data from Baptist Memorial Hospitals in Memphis (TN, USA). Reteplase appears to break up stroke-causing clots a majority of the time when administered directly into the clot by a specialist, such as an interventional radiologist, and appears to cause less bleeding than tPA.



Related Links:
Society of Cardiovascular & Interventional Radiology (SCVIR)

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.